-
-
-
-
-
-
-
Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
-
-
-
-
-
-
-
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Insmed (INSM) Prices 9.615M Share Common Offering at $26/Sh
-
-
-
-
-
-
-
Insmed Announces Proposed Public Offering of Convertible Senior Notes
-
-
-
-
-
-
-
Insmed (INSM) Plans $250M Offering of Common Stock
-
-
-
-
-
-
-
Insmed (INSM) Prices 10M Common Offering at $20.65/Share
-
-
-
-
-
-
-
Insmed (INSM) Commences $80M Common Stock Offering
-
1,167,059 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

